Anti-metastasis therapy via nanoparticle mediated drug delivery

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1124161

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Most cancer deaths are caused by tumours that have spread to other vital organs, a process called metastasis. The common treatment for metastatic disease is chemotherapy, but the amount given is limited by toxicity to the patient. In this project, we are developing a way of delivering the therapies only to tumour cells, thereby sparing normal tissues. We are using nanoparticles that have a molecule on their surface that directs the therapy directly to tumour cells.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2020

Funding Scheme: Project Grants

Funding Amount: $835,199.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Nanomedicine

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

breast cancer | chemotherapy | metastatic disease | nanotechnology | targeted therapy

Related Links